September 10, 2025Biomaterials Science

Next-Generation Nanocarriers for Colorectal Cancer: Passive, Active, and Stimuli-Responsive Strategies for Precision Therapy

View Full Paper

Ask AI

Bookmark

Nanocarrier systems significantly enhance drug accumulation in colorectal cancer tumors, improving treatment efficacy.
The study evaluates passive, active, and stimuli-responsive strategies for improving precision therapy in CRC.
These advanced drug delivery systems highlight the potential for more effective management of colorectal cancer.
The analysis indicates that personalized treatment approaches may lead to better outcomes for patients with CRC.

Implication

This review shows enhanced drug delivery in colorectal cancer, highlighting active and passive strategies.

Abstract

Colorectal cancer (CRC) remains a major global health burden, necessitating more effective and selective therapeutic approaches. Nanocarrier-based drug delivery systems offer significant advantages by enhancing drug accumulation in tumors, reducing...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mohamed et al. (2025) studied this question.

synapsesocial.com/papers/68c18bf99b7b07f3a06140cf https://doi.org/10.1039/d5bm01176k

View Full Paper

Ask AI

Bookmark

Implication

This review shows enhanced drug delivery in colorectal cancer, highlighting active and passive strategies.

Next-Generation Nanocarriers for Colorectal Cancer: Passive, Active, and Stimuli-Responsive Strategies for Precision Therapy

Key Points

Implication

Abstract

Discussion

Cite This Study

Next-Generation Nanocarriers for Colorectal Cancer: Passive, Active, and Stimuli-Responsive Strategies for Precision Therapy

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading